Cerveau Tapped for Alzheimer’s Research

Cerveau has signed a research agreement through which it will supply its early-stage imaging agent to assess the stages of Alzheimer’s disease and other neurodegenerative diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *